InsiderSignalSign in

SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

4 h delay

Buys Sells Buys and sells Any size $100K+$1M+

Deciphera Pharmaceuticals, Inc.

Matthew L Sherman · EVP and Chief Medical Officer

$41K−2.0%Feb 20

Deciphera Pharmaceuticals, Inc.

Thomas Patrick Kelly · CFO

$47K−4.0%Feb 20

Deciphera Pharmaceuticals, Inc.

Jama Pitman · SVP and Chief Development Officer

$35K−3.0%Feb 20

Deciphera Pharmaceuticals, Inc.

Daniel C. Martin · Chief Commercial Officer

$35K−4.0%Feb 20

Deciphera Pharmaceuticals, Inc.

Matthew L Sherman · EVP and Chief Medical Officer

$35K−3.0%Jan 18

Deciphera Pharmaceuticals, Inc.

Thomas Patrick Kelly · CFO

$35K−4.0%Jan 18

Deciphera Pharmaceuticals, Inc.

Steven L. Hoerter · President and CEO

$471K−30.0%Dec 14

Deciphera Pharmaceuticals, Inc.

Thomas Patrick Kelly · CFO

$43K−4.0%Dec 14

Deciphera Pharmaceuticals, Inc.

Jama Pitman · Insider

$26K−3.0%Dec 14

Deciphera Pharmaceuticals, Inc.

Daniel C. Martin · Chief Commercial Officer

$27K−3.0%Dec 14

Deciphera Pharmaceuticals, Inc.

Matthew L Sherman · EVP and Chief Medical Officer

$43K−3.0%Dec 14

Deciphera Pharmaceuticals, Inc.

Daniel C. Martin · Chief Commercial Officer

$224K−28.0%Dec 1

Deciphera Pharmaceuticals, Inc.

Steven L. Hoerter · President and CEO

$259K−35.0%Oct 31

Deciphera Pharmaceuticals, Inc.

Matthew L Sherman · EVP and Chief Medical Officer

$28K−3.0%Oct 31

Deciphera Pharmaceuticals, Inc.

Thomas Patrick Kelly · CFO

$28K−4.0%Oct 31

Deciphera Pharmaceuticals, Inc.

Matthew L Sherman · EVP and Chief Medical Officer

$37K−3.0%Oct 4

Deciphera Pharmaceuticals, Inc.

Steven L. Hoerter · President and CEO

$117K−100.0%Mar 23

Deciphera Pharmaceuticals, Inc.

Steven L. Hoerter · President and CEO

$481K−80.0%Feb 16

Deciphera Pharmaceuticals, Inc.

Daniel Lee Flynn · Chief Scientific Officer

$51K−1.0%Jan 19

Deciphera Pharmaceuticals, Inc.

Jama Pitman · Insider

$34K−4.0%Jan 19

Deciphera Pharmaceuticals, Inc.

Matthew L Sherman · EVP and Chief Medical Officer

$51K−3.0%Jan 19

Deciphera Pharmaceuticals, Inc.

Daniel C. Martin · Chief Commercial Officer

$34K−3.0%Jan 19

Deciphera Pharmaceuticals, Inc.

Thomas Patrick Kelly · CFO

$51K−5.0%Jan 19

Deciphera Pharmaceuticals, Inc.

Matthew L Sherman · EVP and Chief Medical Officer

$48K−3.0%Oct 5

Deciphera Pharmaceuticals, Inc.

Matthew L Sherman · EVP and Chief Medical Officer

$88K−5.0%Oct 6

Deciphera Pharmaceuticals, Inc.

Michael Douglas Taylor · Director

$369K−100.0%May 5

Deciphera Pharmaceuticals, Inc.

James Arthur Bristol · Director

$323K−100.0%Apr 21

Deciphera Pharmaceuticals, Inc.

James Arthur Bristol · Director

$644K−100.0%Apr 14

Deciphera Pharmaceuticals, Inc.

Michael Douglas Taylor · Director

$365K−100.0%Apr 6

Deciphera Pharmaceuticals, Inc.

Michael Douglas Taylor · Director

$352K−100.0%Mar 3

Deciphera Pharmaceuticals, Inc.

Thomas Patrick Kelly · CFO

$26K−3.0%Feb 18

Deciphera Pharmaceuticals, Inc.

Michael Douglas Taylor · Director

$362K−100.0%Feb 3

Deciphera Pharmaceuticals, Inc.

James Arthur Bristol · Director

$352K−100.0%Jan 20

Deciphera Pharmaceuticals, Inc.

Michael Douglas Taylor · Director

$1.1M−100.0%Jan 6

Deciphera Pharmaceuticals, Inc.

Michael Douglas Taylor · Director

$1.2M−100.0%Dec 3

Deciphera Pharmaceuticals, Inc.

Michael Douglas Taylor · Director

$972K−100.0%Nov 6

Deciphera Pharmaceuticals, Inc.

Michael Douglas Taylor · Director

$1.3M−100.0%Nov 4

Deciphera Pharmaceuticals, Inc.

James Arthur Bristol · Director

$1.3M−100.0%Oct 13

Deciphera Pharmaceuticals, Inc.

Michael Douglas Taylor · Director

$6.5M−100.0%Oct 5

Deciphera Pharmaceuticals, Inc.

Thomas Patrick Kelly · CFO

$150K−30.0%Sep 16

Deciphera Pharmaceuticals, Inc.

Thomas Patrick Kelly · CFO

$416K−56.0%Sep 10

Deciphera Pharmaceuticals, Inc.

James Arthur Bristol · Director

$1.3M−100.0%Jul 13

Deciphera Pharmaceuticals, Inc.

Michael Douglas Taylor · Director

$7.2M−100.0%Jul 6

Deciphera Pharmaceuticals, Inc.

Patricia L Allen · Director

$691K−100.0%Jun 5

Deciphera Pharmaceuticals, Inc.

Thomas Patrick Kelly · CFO

$662K−63.0%May 13

Deciphera Pharmaceuticals, Inc.

Michael Douglas Taylor · Director

$1.4M−100.0%Apr 30

Deciphera Pharmaceuticals, Inc.

Michael Douglas Taylor · Director

$1.1M−100.0%Apr 21

Deciphera Pharmaceuticals, Inc.

Michael Douglas Taylor · Director

$52K−100.0%Apr 16

Deciphera Pharmaceuticals, Inc.

James Arthur Bristol · Director

$1.0M−100.0%Apr 13

Deciphera Pharmaceuticals, Inc.

Michael Douglas Taylor · Director

$2.8M−100.0%Apr 3

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.